News | August 08, 2023
Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
Subscribe To Our Newsletter & Stay Updated
